{
  "report_rows": [
    {
      "kpi": "Adjusted EPS (FQ1 FY27)",
      "prediction": "BEAT",
      "answer": "pred ~$2.55 vs. cons $2.49",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total Revenue (FQ1 FY27)",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.49B vs. cons $1.495B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "AST segment constant-currency organic revenue growth (FQ1 FY27)",
      "prediction": "MISS",
      "answer": "pred ~3% vs. cons/implied ~6%",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY27 Adjusted EPS guidance (reaffirm/raise)",
      "prediction": "UNCHANGED",
      "answer": "guide ~$11.10-$11.30 (mid $11.20) vs. cons $11.20 (FY2027)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY27 As-reported revenue growth guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~7-8% vs. cons ~7.5% (FY2027)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY27 AST constant-currency organic growth outlook",
      "prediction": "UNCHANGED",
      "answer": "guide ~7-8% full year (soft 1H, stronger 2H) vs. cons ~7% (FY2027)",
      "confidence": "LOW"
    },
    {
      "kpi": "FY27 EBIT margin expansion guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~+50bps vs. cons ~+45-50bps (FY2027)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY27 Share repurchase run-rate commentary",
      "prediction": "BETTER",
      "answer": "guide ~$200-300M/yr vs. prior actual run-rate ~$130M (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 1.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -0.4,
  "day5_path": "FADE",
  "day5_rationale": "Base case is a modest EPS beat (Q1 bar set low/conservative, especially on AST) with full-year FY27 guidance simply reaffirmed rather than raised \u2014 a 'beat-and-reaffirm' that should produce a small positive pop given how much AST-destocking/tariff pessimism is already in the stock after the June low and the July 28 dividend/buyback-driven re-rate. But because management explicitly front-loaded caution into 1H (AST guided soft in Q1/Q2, needing a 'significantly improving Q3' and 'pretty easy Q4 comps' to hit the 7-8% full-year AST target), any Q1 AST organic print near the low single digits forces analysts to model a steeper 2H AST ramp to keep FY27 numbers intact. That out-period math (higher implied H2 AST growth requirement, tax-rate step-up to ~25%, and no visible raise to the $11.10-$11.30 EPS range despite the Q1 beat) tends to get partially unwound over the following days as sell-side notes flag the back-half-loaded risk, producing a fade rather than a durable follow-through, even though a clean beat keeps the drawdown modest versus the initial reaction.",
  "day5_confidence": "LOW"
}